Manulife (Manufacturers Life Insurance)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-67,981
Closed -$231K 2931
2018
Q3
$231K Sell
67,981
-9,104
-12% -$30.9K ﹤0.01% 2679
2018
Q2
$290K Buy
77,085
+3,935
+5% +$14.8K ﹤0.01% 2816
2018
Q1
$299K Sell
73,150
-2,029
-3% -$8.29K ﹤0.01% 2720
2017
Q4
$349K Buy
75,179
+1,648
+2% +$7.65K ﹤0.01% 2578
2017
Q3
$522K Buy
73,531
+7,370
+11% +$52.3K ﹤0.01% 2243
2017
Q2
$477K Buy
66,161
+2,564
+4% +$18.5K ﹤0.01% 2330
2017
Q1
$392K Buy
63,597
+7,638
+14% +$47.1K ﹤0.01% 2357
2016
Q4
$328K Sell
55,959
-331
-0.6% -$1.94K ﹤0.01% 2411
2016
Q3
$299K Buy
56,290
+109
+0.2% +$579 ﹤0.01% 2455
2016
Q2
$372K Sell
56,181
-13,445
-19% -$89K ﹤0.01% 2228
2016
Q1
$328K Buy
69,626
+860
+1% +$4.05K ﹤0.01% 2251
2015
Q4
$348 Hold
68,766
﹤0.01% 2263
2015
Q3
$242 Sell
68,766
-210,254
-75% -$740 ﹤0.01% 2491
2015
Q2
$2.79K Sell
279,020
-192
-0.1% -$2 ﹤0.01% 1326
2015
Q1
$3.56K Buy
279,212
+48,895
+21% +$623 ﹤0.01% 1207
2014
Q4
$3.26K Sell
230,317
-28,581
-11% -$404 ﹤0.01% 1181
2014
Q3
$3.56K Buy
258,898
+10,263
+4% +$141 0.01% 1151
2014
Q2
$3.82M Buy
248,635
+182,208
+274% +$2.8M 0.01% 1128
2014
Q1
$1.13K Buy
66,427
+4,539
+7% +$77 ﹤0.01% 1551
2013
Q4
$801 Buy
61,888
+1,977
+3% +$26 ﹤0.01% 1745
2013
Q3
$605 Buy
59,911
+998
+2% +$10 ﹤0.01% 1873
2013
Q2
$440K Buy
+58,913
New +$440K ﹤0.01% 1978